
Nearly one in nine U.S. children has been diagnosed with ADHD. Cenextra, a new digital treatment developed at @FloridaState and licensed by Sky Therapeutics, is the first ADHD treatment to receive the @US_FDA Breakthrough Device Designation.
Built on years of @NIH-supported research, Cenextra uses a patented series of mental exercises to strengthen executive functioning, expanding non-medication options for in children with ADHD.
#FSUHealth | @IGNITEFSU
Read more at news.fsu.edu/news/health-me…

English



























